Exozymes (EXOZ) EPS (Basic) (2023 - 2026)
Exozymes (EXOZ) posted quarterly EPS (Basic) of -$0.33 for Q4 2025, down 257.21% year-over-year from $0.21 in Q4 2024, and down 20.78% quarter-over-quarter from -$0.27 in Q3 2025.
Exozymes (EXOZ) EPS (Basic) (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported EPS (Basic) for 3 consecutive years, with -$0.33 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) fell 257.21% year-over-year to -$0.33; the TTM figure through Dec 2025 stood at -$1.11 (down 56.67% YoY), while the FY2025 annual figure was -$1.09, down 54.89% from the prior year.
- EPS (Basic) fell to -$0.33 in Q4 2025 per EXOZ's latest filing, from -$0.27 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.08 in Q3 2023 and bottomed at -$0.33 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.21 across 3 years, with a median of -$0.22 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 45.45% — and 2025, when it slumped 257.21%.
- Exozymes' EPS (Basic) stood at -$0.17 in 2023, then soared by 45.45% to -$0.09 in 2024, then plunged by 257.21% to -$0.33 in 2025.
- Business Quant data shows EXOZ's EPS (Basic) at -$0.33 in Q4 2025, -$0.27 in Q3 2025, and -$0.28 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.33 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -0.22 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.22 |
| Mar 31, 2024 | -0.16 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.08 |